Normoftal is a short synthetic peptide targeting retinal cells to improve protein synthesis, protect against oxidative/inflammatory damage, and promote repair. Used to support vision in glaucoma, diabetic retinopathy, and AMD.
Normoftal
Also known as: AKS-G (Lys-Glu)
Overview
Benefits
- Retinal/photoreceptor regeneration support
- Improved visual clarity and contrast
- Reduced oxidative damage
- Dampened ocular inflammation
- Enhanced retinal neuron survival/signaling
- Potential preservation of telomere length
Consider This Peptide If You Want To
- Experience early macular degeneration or diabetic retinopathy
- Seek retinal protection and slowed ocular aging
Dosage & Administration
Dosage Guidelines
Recommended Dosage
• Amount:1 mg
• Frequency:daily
• Duration:4 weeks
• Rest Period:
• Time of Day:morning
• Ingestion:oral
Take 30 minutes before meals for optimal absorption. Monitor visual function improvements.
Administration Routes:Oral
Research Findings on Dosage:
Oral Administration
• Commonly Reported Dosage: 1--2 capsules, 1--2x/day
• Duration: 30 days
• Repeat Cycle: Every 4--6 months for maintenance; 2--3 months for therapeutic use
• Administration Notes: Take 30 minutes before meals for optimal absorption.
Mechanism of Action
Mechanism of Action
How this peptide works in the body
Chromatin Remodeling and Gene Activation
Normoftal interacts with chromatin in retinal cells by disrupting tight nucleosome packaging, particularly via acetylation of histone H3 at lysine 9 and lysine 27 (H3K9ac, H3K27ac), while reducing repressive marks such as H3K9me3. This transition from heterochromatin to euchromatin opens promoter regions of genes related to retinal repair and cellular maintenance. RNA polymerase II recruitment is increased at loci encoding cytoskeletal proteins and synaptic scaffolds, crucial for visual signal transmission.
Epigenetic Modulation
This peptide promotes a transcriptionally active chromatin landscape by increasing p300/CBP-dependent histone acetyltransferase activity while repressing class I and II HDACs. It also shows potential to influence TET-mediated DNA hydroxymethylation, contributing to long-term gene reactivation. Normoftal may stabilize open chromatin via interaction with scaffold attachment regions (SARs), preserving access for transcription factors involved in neurotrophic signaling.
Neuroprotection and Synaptic Support
Normoftal enhances expression of brain-derived neurotrophic factor (BDNF) and synaptophysin through CREB-mediated transcription, aiding in retinal ganglion cell survival and synaptic plasticity. It maintains neurotransmitter balance by increasing vesicular glutamate transporter (VGLUT1) expression while suppressing excitotoxic NMDA receptor overactivation. Its impact on axon guidance proteins, such as GAP-43, supports regeneration of damaged retinal circuits.
Antioxidant Activity
Normoftal activates the Nrf2--ARE pathway by preventing KEAP1-mediated ubiquitination of Nrf2, thereby increasing transcription of antioxidant enzymes including SOD1, catalase, and glutathione peroxidase. It also upregulates thioredoxin reductase and peroxiredoxin systems, which play roles in detoxifying hydrogen peroxide and lipid peroxides in photoreceptors. Lys-Glu's acidic nature may directly chelate iron and copper ions, mitigating Fenton chemistry in the retina.
Anti-Inflammatory Effects
Normoftal reduces NF-κB activation in microglial and Müller glial cells, leading to decreased transcription of TNF-α, IL-1β, and IL-6. It suppresses COX-2 and iNOS expression in retinal pigment epithelial (RPE) cells, reducing prostaglandin and nitric oxide production. This mechanism helps prevent chronic low-grade inflammation that underlies age-related retinal degeneration.
Telomere Maintenance and Cellular Longevity
Early-stage studies indicate that Normoftal may upregulate TERT (telomerase reverse transcriptase) mRNA in RPE cells, potentially by alleviating epigenetic silencing at the TERT promoter. This activity helps preserve telomere length and replicative potential in retinal cells, contributing to tissue longevity and resistance to senescence-induced dysfunction.
Consider Stacking With
- Visoluten
- Endoluten
- Ventfort
- Pinealon
- Thymalin
Side Effects & Cautions
Common Side Effects
- None reported
Cautions
- Use under supervision if pregnant/nursing/immunocompromised
- Not a substitute for disease-modifying therapy in advanced disease
Rare Side Effects
- Rare hypersensitivity
Research & References
Research Highlights
Khavinson et al., 2022, IJMS: Described the cellular uptake pathways for ultrashort peptides like Normoftal, confirming tissue penetration and nuclear localization.
Umnov et al., 2013, Russian Journal of Gerontology: Demonstrated improved electroretinography outcomes and visual fields in aged subjects using Normoftal.
Trofimova et al., 2012, A4M Proceedings: Reported clinical improvement in visual acuity among patients with diabetic retinopathy and macular degeneration.
Khavinson VKh, 2002: Reviewed the role of peptide bioregulators in restoring retinal function via chromatin-based gene activation.
References
Khavinson V, Linkova N, Kozhevnikova E, Dyatlova A, Petukhov M. "Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers." Int J Mol Sci. 2022;23(14):7733.
Umnov RS, et al. "Neuroprotective effects of peptide bioregulators in people of various age." Russian J Gerontology. 2013.
Trofimova SV, et al. "Latest inventions in macular degeneration and diabetic retinopathy." A4M Conference Proceedings. 2012.
Khavinson VKh. "Peptide regulation of aging." 2002.